Circadian Timing Optimizes Allo-HSCT to Prevent aGVHD: A Breakthrough in Chrono-Immunotherapy. Huang X, Xu H, Xia Y, Lu Z, et al. Stem Cells 2026 Jan 7:sxaf084. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang X, Xu H, Xia Y, Lu Z, et al. Circadian Timing Optimizes Allo-HSCT to Prevent aGVHD: A Breakthrough in Chrono-Immunotherapy. Stem Cells 2026 Jan 7:sxaf084. doi: 10.1093.
PMID: 41499429